What is the current Reusable Core Biopsy Instrument market size?

The current Reusable Core Biopsy Instrument market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Reusable Core Biopsy Instrument market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driving future outlook.

What are the key drivers of the Reusable Core Biopsy Instrument market?

Increasing cancer prevalence and demand for minimally invasive procedures are key drivers of market growth.

What are the major challenges facing the Reusable Core Biopsy Instrument market?

High costs and limited reimbursement are significant challenges hindering market expansion.

Which regions are leading the Reusable Core Biopsy Instrument market?

North America and Europe are regional leaders, driven by advanced healthcare infrastructure.

Who are the top companies in the Reusable Core Biopsy Instrument market?

Major players include Medtronic, Boston Scientific, and Becton Dickinson, driving market innovation.

What future opportunities exist in the Reusable Core Biopsy Instrument market?

Emerging markets and technological advancements present significant future opportunities for growth.

How will technology impact the Reusable Core Biopsy Instrument market?

Advances in imaging and diagnostic technologies will significantly impact market size and future outlook.

What is the current regulatory landscape for the Reusable Core Biopsy Instrument market?

Stringent regulations and standards govern market operations, ensuring patient safety and product efficacy.

How will the Reusable Core Biopsy Instrument market evolve in the next 5 years?

The market will experience steady growth, driven by increasing adoption of reusable instruments and expanding applications.

Reusable Core Biopsy Instrument Market Metrics & Forecast Analysis 2033

Reusable Core Biopsy Instrument by Application (Hospitals, Academic and Research Institutes, Diagnostic and Imaging Centers), by Types (Diameter 14G, Diameter 16G, Diameter 18G, Diameter 20G), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Reusable Core Biopsy Instrument Market Overview

The Reusable Core Biopsy Instrument market refers to the industry that produces and distributes reusable instruments used for core biopsy procedures. As a crucial segment of the medical device industry, the Reusable Core Biopsy Instrument market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by an increasing demand for minimally invasive diagnostic procedures. The industry expansion is expected to be fueled by advancements in technology, growing awareness about the importance of early cancer diagnosis, and an aging population. The scope of this market encompasses various types of reusable core biopsy instruments, including spring-loaded and vacuum-assisted devices, used in hospitals, clinics, and other healthcare facilities.

Loading chart…

The Reusable Core Biopsy Instrument market is expected to grow at a CAGR of 7.5% from 2026 to 2033, driven by macro drivers such as an increasing prevalence of cancer, a growing demand for minimally invasive procedures, and advancements in technology. Key forces shaping the industry include technology shifts, such as the development of more accurate and efficient biopsy instruments, regulations that promote the use of reusable instruments to reduce medical waste, and consumer behavior that favors minimally invasive procedures. The largest region for the Reusable Core Biopsy Instrument market is North America, while the fastest-growing region is Asia-Pacific. The market is highly competitive, with major players competing based on factors such as product quality, price, and customer service.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GEOTEK MEDICAL; BD; PAJUNK; Medax; BIP Medical; Möller Medical; Seedos; Mdl Srl; Vigeo Srl; STERYLAB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Reusable Core Biopsy Instrument market is poised for significant growth, driven by factors such as increasing demand for minimally invasive procedures and advancements in medical technology. The Reusable Core Biopsy Instrument market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advancements in medical technology, such as improved imaging capabilities and increased precision, are driving the adoption of reusable core biopsy instruments, contributing to the growth of the Reusable Core Biopsy Instrument market

The rising prevalence of chronic diseases, such as cancer, is fueling the demand for diagnostic procedures, including core biopsies, which in turn is driving the growth of the Reusable Core Biopsy Instrument market size

Restraints2 items

Stringent regulatory requirements and high costs associated with the development and maintenance of reusable core biopsy instruments are hindering the growth of the Reusable Core Biopsy Instrument market

The risk of cross-contamination and infection associated with reusable instruments is a significant concern, which may limit the adoption of reusable core biopsy instruments and impact the Reusable Core Biopsy Instrument market size

Opportunities2 items

Emerging markets, particularly in Asia and Latin America, offer significant growth opportunities for the Reusable Core Biopsy Instrument market, driven by increasing demand for diagnostic procedures and improving healthcare infrastructure

The development of innovative and cost-effective reusable core biopsy instruments can help manufacturers to differentiate themselves and gain a competitive edge in the Reusable Core Biopsy Instrument market

Challenges2 items

The Reusable Core Biopsy Instrument market faces intense competition, with several established players and new entrants, which can make it challenging for manufacturers to maintain their market share and achieve a favorable growth forecast

The need for ongoing education and training for healthcare professionals to ensure the safe and effective use of reusable core biopsy instruments is a significant challenge, which can impact the adoption and growth of the Reusable Core Biopsy Instrument market

Market Segmentation

Loading chart…

The Reusable Core Biopsy Instrument market can be segmented based on Application, which includes subtypes such as breast biopsy, liver biopsy, and prostate biopsy. Each of these subtypes contributes to the overall market size, with breast biopsy being a significant contributor due to the high prevalence of breast cancer. The Reusable Core Biopsy Instrument segmentation is crucial in understanding the market dynamics and trends.

Another important segmentation category is Types, which includes subtypes such as spring-loaded and vacuum-assisted biopsy instruments. These subtypes differ in terms of their functionality and usage, with spring-loaded instruments being more commonly used for breast biopsies and vacuum-assisted instruments being used for more complex procedures. Understanding the market taxonomy of Reusable Core Biopsy Instruments is essential for industry players to develop targeted strategies and products.

Reusable Core Biopsy Instrument Segmentation Breakdown9 items

Application

Hospitals

Academic and Research Institutes

Diagnostic and Imaging Centers

Types

Diameter 14G

Diameter 16G

Diameter 18G

Diameter 20G

Regional Insights

Loading chart…

The Reusable Core Biopsy Instrument market growth is anticipated to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is expected to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. In Europe, drivers include policies supporting medical device innovation, a strong ecosystem, and significant investments in research and development. Asia Pacific's growth is driven by increasing adoption, rising demographics, and growing infrastructure. Latin America's growth is driven by improving infrastructure, increasing adoption, and favorable policies. The Middle East & Africa region is driven by growing investments, increasing adoption, and developing infrastructure.

The regional forecast indicates a significant Reusable Core Biopsy Instrument market growth in Asia Pacific, with a projected regional forecast of 10% annually. This growth is expected to be driven by the increasing demand for advanced medical technologies, rising demographics, and growing infrastructure.

Competitive Landscape

The Reusable Core Biopsy Instrument market is moderately consolidated, driven by a mix of global players and local companies. The Reusable Core Biopsy Instrument competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory compliance, while local companies emphasize distribution and pricing strategies.

Companies employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies must develop unique value propositions, leveraging technology, service models, channel strength, customization, and cost advantages. The following companies illustrate different strategic focuses:

GEOTEK MEDICAL: regional expansion

BD: premium pricing

PAJUNK: OEM tie-ups

Medax: innovation pipeline

BIP Medical: local manufacturing

Möller Medical: vertical integration

Key Reusable Core Biopsy Instrument Companies10 items

GEOTEK MEDICAL

PAJUNK

Medax

BIP Medical

Möller Medical

Seedos

Mdl Srl

Vigeo Srl

STERYLAB

Market Ecosystem

The Reusable Core Biopsy Instrument ecosystem encompasses a network of participants that create and capture value across the upstream, midstream, and downstream segments. This ecosystem includes technology providers, suppliers, integrators, channels, and end users, all of which contribute to the development, manufacturing, and distribution of reusable core biopsy instruments. The ecosystem's boundaries are defined by the flow of value from raw material suppliers to end users, with each participant playing a distinct role in the value chain analysis.

Raw material suppliers — provide materials for instrument manufacturing

OEMs / manufacturers — design and produce reusable core biopsy instruments

Technology providers — develop innovative technologies for instrument enhancement

Distributors / channel partners — facilitate instrument distribution to end users

Service providers / after-sales — offer maintenance and repair services for instruments

End users / buyers — purchase and utilize reusable core biopsy instruments

Regulators/standards bodies — establish guidelines and standards for instrument safety and efficacy

The flow of value within the Reusable Core Biopsy Instrument ecosystem is influenced by various control points, including regulatory bodies that set standards for instrument safety and efficacy. Dependency risks, such as input constraints and approval timelines, can also impact the ecosystem's dynamics. Furthermore, switching costs, partnerships, and interoperability requirements can affect the relationships between participants, while regional differences in regulations and market demands can lead to variations in the ecosystem's structure and functioning across different areas.

Recent Industry Insights

The Reusable Core Biopsy Instrument industry has witnessed significant developments over the last 12-18 months, shaping the Reusable Core Biopsy Instrument industry trends. Notable partnerships between key players have led to the creation of innovative products, enhancing the overall efficiency of biopsy procedures. Furthermore, strategic mergers and acquisitions have resulted in the expansion of product portfolios, strengthening the market presence of major companies.

Recent product launches have focused on improving the accuracy and comfort of biopsy procedures, with an emphasis on minimally invasive techniques. Additionally, regulatory changes have prompted companies to adapt and comply with new standards, driving the development of safer and more reliable instruments. These advancements have contributed to a shift in consumer preferences, with a growing demand for reusable and sustainable biopsy instruments, ultimately influencing the Reusable Core Biopsy Instrument industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Reusable Core Biopsy Instrument market outlook. The market exhibits moderate attractiveness due to increasing demand for minimally invasive procedures and a growing focus on sustainability. Competitive intensity is relatively high, with key players investing in innovation and technological advancements. The long-term outlook appears promising, driven by rising cancer incidence rates and an expanding patient base. The innovation landscape is characterized by ongoing research and development in biopsy techniques and instrument design. However, the demand–supply balance may be affected by regulatory challenges and supply chain disruptions. Key risk factors include market fluctuations and stringent regulations, which may impact market growth.

12 items

1. Executive Summary

2. Reusable Core Biopsy Instrument Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Reusable Core Biopsy Instrument Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Reusable Core Biopsy Instrument Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Reusable Core Biopsy Instrument Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Reusable Core Biopsy Instrument Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Reusable Core Biopsy Instrument Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Reusable Core Biopsy Instrument Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Reusable Core Biopsy Instrument Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Reusable Core Biopsy Instrument Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Reusable Core Biopsy Instrument Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Reusable Core Biopsy Instrument Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Reusable Core Biopsy Instrument Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Reusable Core Biopsy Instrument Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Reusable Core Biopsy Instrument Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Reusable Core Biopsy Instrument Market Competition by Key Manufacturers

9.1. Global Reusable Core Biopsy Instrument Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Reusable Core Biopsy Instrument: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. GEOTEK MEDICAL

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. BD

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. PAJUNK

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Medax

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. BIP Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Möller Medical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Seedos

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Mdl Srl

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Vigeo Srl

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. STERYLAB

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Reusable Core Biopsy Instrument Market

Figure 4: Global Reusable Core Biopsy Instrument Market: Drivers

Figure 5: Global Reusable Core Biopsy Instrument Market: Challenges

Figure 6: Global Reusable Core Biopsy Instrument Market: Trends

Figure 7: Global Reusable Core Biopsy Instrument Market: Opportunity

Figure 8: Global Reusable Core Biopsy Instrument Market: Restraint

Figure 9: Global Reusable Core Biopsy Instrument Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Reusable Core Biopsy Instrument Market Value (USD Million) By Region

Figure 19: Global Reusable Core Biopsy Instrument Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Reusable Core Biopsy Instrument Market Value (USD Million) By Region

Figure 27: Global Reusable Core Biopsy Instrument Market Share (%) By: Regions (2032)

Figure 28: Global Reusable Core Biopsy Instrument Market Volume (K) By Region

Figure 29: Global Reusable Core Biopsy Instrument Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Reusable Core Biopsy Instrument Market Value (USD Million) By Region

Figure 37: Global Reusable Core Biopsy Instrument Market Share (%) By: Regions (2032)

Figure 38: Global Reusable Core Biopsy Instrument Market Volume (K) By Region

Figure 39: Global Reusable Core Biopsy Instrument Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Reusable Core Biopsy Instrument Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Reusable Core Biopsy Instrument Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Reusable Core Biopsy Instrument Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Reusable Core Biopsy Instrument Market Value (USD Million) By Region

Table 14: Global Reusable Core Biopsy Instrument Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Reusable Core Biopsy Instrument Market Volume (K) By Region

Table 31: Global Reusable Core Biopsy Instrument Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Reusable Core Biopsy Instrument Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Reusable Core Biopsy Instrument Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Reusable Core Biopsy Instrument Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: GEOTEK MEDICAL Basic Information And Sales Area

Table 52: GEOTEK MEDICAL. Products Portfolio

Table 53: BD Basic Information And Sales Area

Table 54: BD. Products Portfolio

Table 55: PAJUNK Basic Information And Sales Area

Table 56: PAJUNK. Products Portfolio

Table 57: Medax Basic Information And Sales Area

Table 58: Medax. Products Portfolio

Table 59: BIP Medical Basic Information And Sales Area

Table 60: BIP Medical. Products Portfolio

Table 61: Möller Medical Basic Information And Sales Area

Table 62: Möller Medical. Products Portfolio

Table 63: Seedos Basic Information And Sales Area

Table 64: Seedos. Products Portfolio

Table 65: Mdl Srl Basic Information And Sales Area

Table 66: Mdl Srl. Products Portfolio

Table 67: Vigeo Srl Basic Information And Sales Area

Table 68: Vigeo Srl. Products Portfolio

Table 69: STERYLAB Basic Information And Sales Area

Table 70: STERYLAB. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Reusable Core Biopsy Instrument Market Value (USD Million) By Region

Table 80: Global Reusable Core Biopsy Instrument Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Reusable Core Biopsy Instrument Market Volume (K) By Region

Table 97: Global Reusable Core Biopsy Instrument Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Reusable Core Biopsy Instrument Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	GEOTEK MEDICAL; BD; PAJUNK; Medax; BIP Medical; Möller Medical; Seedos; Mdl Srl; Vigeo Srl; STERYLAB
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Reusable Core Biopsy Instrument Segmentation Breakdown9 items

Application

Hospitals

Academic and Research Institutes

Diagnostic and Imaging Centers

Types

Diameter 14G

Diameter 16G

Diameter 18G

Diameter 20G

Regional Insights

Loading chart…

Competitive Landscape

GEOTEK MEDICAL: regional expansion

BD: premium pricing

PAJUNK: OEM tie-ups

Medax: innovation pipeline

BIP Medical: local manufacturing

Möller Medical: vertical integration

Key Reusable Core Biopsy Instrument Companies10 items

GEOTEK MEDICAL

PAJUNK

Medax

BIP Medical

Möller Medical

Seedos

Mdl Srl

Vigeo Srl

STERYLAB

Market Ecosystem

Raw material suppliers — provide materials for instrument manufacturing

OEMs / manufacturers — design and produce reusable core biopsy instruments

Technology providers — develop innovative technologies for instrument enhancement

Distributors / channel partners — facilitate instrument distribution to end users

Service providers / after-sales — offer maintenance and repair services for instruments

End users / buyers — purchase and utilize reusable core biopsy instruments

Regulators/standards bodies — establish guidelines and standards for instrument safety and efficacy

Recent Industry Insights

Analyst Overview

Table of Contents